NEW YORK (Reuters Health) – Pooled clinical-trial data show that teprotumumab improves eye bulging and double vision in patients with active thyroid eye disease, with most patients having long-lasting responses. The data clearly show that teprotumumab “mitigates varying levels of…
Read More
UK to Prioritize Next Stage of COVID Vaccine by Age, Not Job
LONDON (Reuters) – Police and teachers will not jump to the head of the queue in the second phase of Britain’s COVID-19 vaccination rollout, with people instead prioritised by age, officials advising the government said on Friday, describing this as…
Read More